References
- VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- SpencerSEvansDJKarnerCCatesCJInhaled corticosteroids versus long-acting β2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201112CD007033
- VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- SorianoJBLamprechtBRamírezASMortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataLancet Respir Med20153644345025995071
- GoossensLMLeimerIMetzdorfNBeckerKRutten-van MölkenMPDoes the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trialBMC Pulm Med20141416325326750
- TudoricNKoblizekVMiravitllesMGOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) CohortEur Respir J2017494160251828446560
- MenezesAMWehrmeisterFCPerez-PadillaRThe PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017Int J Chron Obstruct Pulmon Dis2017121491150128553101
- Cabrera LópezCCasanova MacarioCMarín TrigoJMComparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and OutcomesAm J Respir Crit Care Med2018197446346929099607
- KahnertKAlterPYoungDThe revised GOLD 2017 COPD categorization in relation to comorbiditiesRespir Med2018134798529413512
- GedebjergASzépligetiSKWackerhausenLHPrediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort studyLancet Respir Med20186320421229331311
- KobayashiSHanagamaMYamandaSIshidaMYanaiMInflammatory biomarkers in asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis2016112117212327660429
- KobayashiSHanagamaMYanaiMIshinomaki COPD Network (ICON) InvestigatorsEarly detection of chronic obstructive pulmonary disease in primary careIntern Med201756233153315828943559
- The Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease)4th edTokyoMedical Review Company, Ltd.2013
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of COPD [updated 2017] Available from: http://www.goldcopd.org/Accessed November 17, 2016
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD Assessment TestRespir Investig20125023439
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- KandaYInvestigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplant201348345245823208313
- SuzukiMMakitaHItoYMClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
- ConnorsAFDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung diseaseAm J Respir Crit Care Med19961544 Pt 19599678887592
- HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
- LainscakMvon HaehlingSDoehnerWBody mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseJ Cachexia Sarcopenia Muscle201122818621766053
- LeeSDHuangMSKangJThe COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patientsRespir Med2014108460060824456695